The PI3K/AKT signalling pathway is frequently activated in cervical cancers due to mutations in the PIK3CA gene [34], and AKT can activate NFκB and mediate IL-6 expression in some cancers [35–37]. This evidence concerns the gene NFKB1 and cervical carcinoma.